Article
11 Nov 2025
The Regulatory Compliance Defense For "Improper" Orange Book Listings
AUTHORS CONTENT
Article
22 Oct 2024
The Interplay: Key Decisions At The Intersection Of Antitrust And Life Sciences - September 2024
Article
01 Aug 2024
The Interplay: Key Decisions At The Intersection Of Antitrust And Life Sciences - July 2024
Article
03 Jul 2024
The Interplay Key Decisions At The Intersection Of Antitrust And Life Sciences - June 2024
Article
04 Jun 2024
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - May 2024
Article
13 May 2024
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - April 2024
Article
04 Apr 2024
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - March 2024
Article
23 Jan 2024
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - January 2024
Article
15 Nov 2023
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - November 2023
Article
16 Oct 2023
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - October 2023
Article
15 Sep 2023
The Interplay: Key Decisions At The Intersection Of Antitrust & Life Sciences - September 2023
Article
15 Dec 2021
District Court Enjoins California's Unprecedented "Reverse Payment" Law
Article
10 Jan 2020
Unprecedented State Law On Pharmaceutical "Reverse Payments" Goes Into Effect
Article
18 May 2018
FDA Publishes List Of Drug Companies Accused Of Hindering Generic Entry: Antitrust Implications
Article
31 Aug 2017
District Court Rejects Direct Purchaser Class for Failure to Satisfy Numerosity Requirement
Article
21 Apr 2017
The Cambridge Handbook Of Antitrust, Intellectual Property, And High Tech
Article
05 Nov 2016
3rd Circ. Weighs In On Product-Hopping
Article
20 Oct 2016
Department Of Justice Obtains Guilty Plea For Obstruction In Merger Investigation
Article
30 Sep 2016
Doryx: Third Circuit Affirms Dismissal Of Product Hopping Claim
Article
08 Dec 2014
Provigil and Nexium: Conflicting Conclusions About Accelerated Entry Provisions in Hatch-Waxman Settlements